A microfluidic hanging-drop-based islet perifusion system for studying glucose-stimulated insulin secretion from multiple individual pancreatic islets
Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes
Liraglutide protects β-cells in novel human islet spheroid models of type 1 diabetes
Effect of IL4 and IL10 on a human in vitro type 1 diabetes model
Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes
HIF-1alpha inhibitor PX-478 preserves pancreatic beta cell function in diabetes
Normoglycemia and physiological cortisone level maintain glucose homeostasis in a pancreas-liver microphysiological system
Quris.AI
Quris.AI is transforming drug safety prediction by uniquely combining advanced AI capabilities with cutting edge 3D organ models, enabling predictions with unprecedented accuracy and scalability. our platform has been extensively validated by leading Pharma companies, including a long term collaboration with Merck GmbH. By predicting safety in human relevant 3D models, our platform significantly increases the likelihood of clinical success and reduces significantly the need for animal testing.
TheWell Bioscience
TheWell Bioscience provides xeno-free, 3D cell culture solutions, empowering research in organoids, regenerative medicine, and drug discovery.